Thus, unedited Alu RNAs found in the Alzheimer’s disease HPC vasculature cohort were potent activators of both IRF and NF-κB pathways while edited Alu RNAs, as found in the NCI cohort, were only weak agonists of these pathways. The gene discussed is NFKB1; the disease is Alzheimer disease.